<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2254-2884</journal-id>
<journal-title><![CDATA[Enfermería Nefrológica]]></journal-title>
<abbrev-journal-title><![CDATA[Enferm Nefrol]]></abbrev-journal-title>
<issn>2254-2884</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Enfermería Nefrológica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2254-28842022000200008</article-id>
<article-id pub-id-type="doi">10.37551/52254-28842022018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Supervivencia del injerto y pacientes postrasplante renal de un hospital de Yucatán, México]]></article-title>
<article-title xml:lang="en"><![CDATA[Graft and patient survival after kidney transplantation in a hospital in Yucatan, Mexico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosado-Alcocer]]></surname>
<given-names><![CDATA[Ligia María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medina-Escobedo]]></surname>
<given-names><![CDATA[Carolina Elizabeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salcedo-Parra]]></surname>
<given-names><![CDATA[María Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Madera-Poot]]></surname>
<given-names><![CDATA[Genny Josefina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gil-Contreras]]></surname>
<given-names><![CDATA[José Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguilar-Castillejos]]></surname>
<given-names><![CDATA[Luis Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma de Yucatán Facultad de Enfermería ]]></institution>
<addr-line><![CDATA[Mérida Yucantán]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,IMSS Mérida Unidad Médica de Alta Especialidad ]]></institution>
<addr-line><![CDATA[Yucatán ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>25</volume>
<numero>2</numero>
<fpage>162</fpage>
<lpage>167</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2254-28842022000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2254-28842022000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2254-28842022000200008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: El trasplante de órganos es considerado como uno de los mayores avances de la medicina, no solo por recuperar la salud, sino por mejorar la calidad de vida de las personas con enfermedades crónicas o terminales.  Objetivo: Identificar la supervivencia del injerto y pacientes sometidos a trasplante renal, así como los factores asociados en un Hospital de Alta Especialidad de Mérida, Yucatán, México.  Material y Método: Estudio epidemiológico, observacional, longitudinal y retrospectivo donde se analizó el 100% de los expedientes disponibles de pacientes con trasplante renal, cuyo procedimiento se realizó a partir de enero de 2010 a diciembre de 2018.  Resultados: La supervivencia global de los pacientes, fue de 96,7% a 1 año (IC:95%: 0,92-0,99) y 90,7% a 5 años (IC:95%: 0,75-0,97). La administración de terapia inmunosupresora previa al trasplante es un factor independiente de protección frente al desenlace de mortalidad o fallo del injerto (p=0,02). La supervivencia del injerto fue de 79,2% a 1 año (IC:95%: 0,71-0,85), y 41,37% a 5 años (IC:95%: 0,27-0,54). La dislipidemia (p=0,01), la diabetes tipo 2 (p=0,09), la isquemia fría (p=0,01), la isquemia caliente (p=0,02), la edad (p=0,03), y el Índice de Masa Corporal (p=0,01) fueron determinantes de la supervivencia del injerto.  Conclusiones: La supervivencia del paciente y del injerto son distintas. La administración de inmunosupresor previo al trasplante afecta la supervivencia del paciente; mientras que factores de riesgo cardiovascular y los tiempos de isquemia estuvieron ligados a la supervivencia del injerto.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Organ transplantation is considered one of the greatest advances in medicine, not only for restoring health, but also for improving the quality of life of people with chronic or terminal diseases.  Objective: To identify graft and renal transplant patient survival and associated factors in a high specialty hospital in Merida, Yucatan, Mexico.  Material and Method: Epidemiological, observational, longitudinal and retrospective study analysing all available records of renal transplant patients whose procedure was performed from January 2010 to December 2018.  Results: Overall patient survival was 96.7% at 1 year (95% CI:0.92-0.99) and 90.7% at 5 years (95% CI:0.75-0.97). The administration of immunosuppressive therapy prior to transplantation is an independent factor for protection against the outcome of mortality or graft failure (p=0.02). Graft survival was 79.2% at 1 year (95% CI:0.71-0.85), and 41.37% at 5 years (95% CI:0.27-0.54). Dyslipidaemia (p=0.01), type 2 diabetes (p=0.09), cold ischaemia (p=0.01), warm ischaemia (p=0.02), age (p=0.03), and body mass index (p=0.01) were determinants of graft survival.  Conclusions: Patient and graft survival are distinct. Pre-transplant immunosuppressant administration affects patient survival, while cardiovascular risk factors and ischaemia times were linked to graft survival.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[supervivencia]]></kwd>
<kwd lng="es"><![CDATA[supervivencia de injerto]]></kwd>
<kwd lng="es"><![CDATA[trasplante de riñón]]></kwd>
<kwd lng="en"><![CDATA[survival]]></kwd>
<kwd lng="en"><![CDATA[graft survival]]></kwd>
<kwd lng="en"><![CDATA[kidney transplantation]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdivia]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado Almora]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Treto Ramírez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Maderos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia en pacientes con trasplante renal Factores pronósticos]]></article-title>
<source><![CDATA[Invest Medicoquir]]></source>
<year>2013</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>253-75</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Marrero]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[González-Molina Alcaide]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultados globales del trasplante renal]]></article-title>
<source><![CDATA[Nefrología al día]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Corte]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rebollo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Baltar]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez-Ude]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores predictores de supervivencia en terapia sustitutiva de la insuficiencia renal crónica terminal (IRCT)]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>1999</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>245-51</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chaparro]]></surname>
<given-names><![CDATA[Leidy]]></given-names>
</name>
<name>
<surname><![CDATA[Rey]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida y estrategias de afrontamiento en pacientes con insuficiencia renal crónica sometidos a hemodiálisis, diálisis peritoneal o trasplante renal]]></article-title>
<source><![CDATA[Rev Colomb Psicol]]></source>
<year>2008</year>
<volume>17</volume>
<page-range>9-26</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kramer]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Tuttle]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Leehey]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Luke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Durazo-Arvizu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shoham]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity management in adults with CKD]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2009</year>
<volume>53</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>151-65</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gluba-Brzozka]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Franczyk]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rysz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients]]></article-title>
<source><![CDATA[Nutrients]]></source>
<year>2019</year>
<volume>11</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ashby]]></surname>
<given-names><![CDATA[VB]]></given-names>
</name>
<name>
<surname><![CDATA[Leichtman]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Rees]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[PX]]></given-names>
</name>
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size]]></article-title>
<source><![CDATA[Clin J Am Soc Nephrol]]></source>
<year>2017</year>
<volume>12</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1148-60</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prémaud]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Filloux]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gatault]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Thierry]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Büchler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Munteanu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2017</year>
<volume>12</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias-Cabrales]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Redondo-Pachón]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Sáez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gimeno]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Güerri]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bermejo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia del injerto renal según la categoría de Banff 2013 en biopsia por indicación]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2016</year>
<volume>36</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>660-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Sociedad Internacional de Nefrología y Federación Internacional de Fundaciones del Riñón]]></article-title>
<source><![CDATA[codigof.mx]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Secretaría de Salud</collab>
<article-title xml:lang=""><![CDATA[Proceso de Donación]]></article-title>
<source><![CDATA[Centro Nacional de Trasplantes]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Secretaría de Salud</collab>
<article-title xml:lang=""><![CDATA[Estado Actual de Receptores, Donación y Trasplantes en México]]></article-title>
<source><![CDATA[Centro Nacional de Trasplantes]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Unidad Médica de Alta Especialidad del IMSS</collab>
<source><![CDATA[Yucatán: informe de registros clínicos]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Yucatán ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Mexicano del Seguro Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eerhart]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Leverson]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Danobeitia]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Blanton]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Zitur]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chlebeck]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Kidney After Liver Transplantation Matched-pair Analysis: Are Kidneys Allocated to Appropriate Patients to Maximize Their Survival?]]></article-title>
<source><![CDATA[Transplantation]]></source>
<year>2020</year>
<volume>104</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>804-12</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-George]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo-Hernández]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Millán-Guerrero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez-Jiménez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Isquemia fría prolongada, factor para rechazo agudo del injerto en trasplante renal cadavérico]]></article-title>
<source><![CDATA[Cir Ciruj]]></source>
<year>2009</year>
<volume>77</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>381-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hansson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mjörnstedt]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lindnér]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours]]></article-title>
<source><![CDATA[Clin Transplant]]></source>
<year>2018</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1-27</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borroto]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[PJL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores influyentes en la supervivencia de los segundos trasplantes renales]]></article-title>
<source><![CDATA[Rev cubana med]]></source>
<year>2018</year>
<volume>57</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-22</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Rawlinson]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Boan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sheppeard]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Waller]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission]]></article-title>
<source><![CDATA[Transplant Direct]]></source>
<year>2018</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Budar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto del índice de masa corporal sobre resultados postrasplante renal]]></article-title>
<source><![CDATA[Rev Mex Tras]]></source>
<year>2012</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-14</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
